Last reviewed · How we verify
Dilactose (Lactose)
At a glance
| Generic name | Lactose |
|---|---|
| Also known as | Lactose powder, placebo granules and tablets, Placebo, Miflonide, Pulmicort |
| Sponsor | Kantonsspital Aarau |
| Drug class | lactose |
| Target | Galectin-9 |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
Approved indications
- Lactose intolerance
Common side effects
Key clinical trials
- The Effect of NP-2006 on Sleep Quality and Health (NA)
- Comparative Analysis of fast-and Slow-absorbable Poly(Lactose-co-glycolide) Sutures in Oral Surgery: a Randomized Controlled Trial. (NA)
- A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis (PHASE2)
- Defining Objective Markers of Compliance for Dietary Therapies in IBS (NA)
- Maternal Betaine Supplementation During Breastfeeding (PHASE1,PHASE2)
- Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder (PHASE2)
- Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis (PHASE4)
- Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dilactose CI brief — competitive landscape report
- Dilactose updates RSS · CI watch RSS
- Kantonsspital Aarau portfolio CI